Good afternoon :)
Place Order
Add to Watchlist

Amrutanjan Health Care Ltd

AMRUTANJAN Share Price

720.001.51% (+10.70)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹2,049 cr, stock is ranked 1,139

Stock is 2.31x as volatile as Nifty

AMRUTANJAN Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹2,049 cr, stock is ranked 1,139

Stock is 2.31x as volatile as Nifty

AMRUTANJAN Performance & Key Metrics

AMRUTANJAN Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
40.317.110.65%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.696.410.79%

AMRUTANJAN Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

AMRUTANJAN Company Profile

Amrutanjan Health Care Limited is engaged in offering ayurvedic balm for headaches, cold and cough. The Company operates through three segments: over-the-counter (OTC) products, beverages and others.

Investor Presentation

View older View older 

May 19, 2025

PDF
View Older Presentations

AMRUTANJAN Similar Stocks (Peers)

Compare with peers Compare with peers 

AMRUTANJAN Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
36.72
36.72
1Y Return
7.46%
7.46%
Buy Reco %
87.50
87.50
PE Ratio
22.80
22.80
1Y Return
0.08%
0.08%
Buy Reco %
73.33
73.33
PE Ratio
58.83
58.83
1Y Return
15.25%
15.25%
Buy Reco %
70.83
70.83
PE Ratio
18.89
18.89
1Y Return
1.76%
1.76%
Buy Reco %
55.17
55.17
PE Ratio
50.40
50.40
1Y Return
17.92%
17.92%
Buy Reco %
81.25
81.25
Compare with Peers

AMRUTANJAN Forecast

AMRUTANJAN Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

AMRUTANJAN

AMRUTANJAN

Income

Balance Sheet

Cash Flow

AMRUTANJAN Income Statement

AMRUTANJAN Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 11.72%, vs industry avg of 10.1%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.11%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 15.18%, vs industry avg of 20.04%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue214.14227.88260.36269.80344.16421.22394.18437.58469.50469.49
Raw Materialssubtract85.6994.01122.16124.05135.18185.96183.71209.67393.62393.61
Power & Fuel Costsubtract1.661.701.872.021.762.663.063.84
Employee Costsubtract29.6733.8533.3639.3641.7048.2348.8147.69
Selling & Administrative Expensessubtract54.3353.1459.9661.4564.7284.6886.9589.23
Operating & Other expensessubtract6.699.104.953.7714.644.7412.5718.89
Depreciation/Amortizationsubtract2.052.913.164.363.673.805.216.066.536.52
Interest & Other Itemssubtract0.250.310.200.340.590.580.220.250.220.22
Taxes & Other Itemssubtract11.9912.9110.179.3720.7123.3913.8116.9718.3018.29
EPS7.466.838.398.5820.9322.9813.6315.4717.5817.59
DPS1.931.532.152.104.204.604.604.604.604.60
Payout ratio0.260.220.260.240.200.200.340.300.260.26

AMRUTANJAN Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual Report Pending

Investor Presentation

May 19PDF
Feb 14PDF
Nov 13PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 4PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

Jun 1PDF
Feb 14PDF
Nov 5PDF
+2 more
FY 2022FY 2022

Annual report

PDF

Investor Presentation

May 25PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual Report Unavailable

FY 2015FY 2015

Annual report

PDF
FY 2014FY 2014

Annual report

PDF
 

AMRUTANJAN Stock Peers

AMRUTANJAN Past Performance & Peer Comparison

AMRUTANJAN Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Amrutanjan Health Care Ltd40.337.110.65%
Sun Pharmaceutical Industries Ltd36.725.540.96%
Cipla Ltd22.803.841.07%
Torrent Pharmaceuticals Ltd58.8314.810.18%

AMRUTANJAN Stock Price Comparison

Compare AMRUTANJAN with any stock or ETF
Compare AMRUTANJAN with any stock or ETF
AMRUTANJAN
Loading...

AMRUTANJAN Holdings

AMRUTANJAN Shareholdings

AMRUTANJAN Promoter Holdings Trend

AMRUTANJAN Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

AMRUTANJAN Institutional Holdings Trend

AMRUTANJAN Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

AMRUTANJAN Shareholding Pattern

AMRUTANJAN Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding46.52%7.55%3.85%2.30%39.78%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

AMRUTANJAN Shareholding History

AMRUTANJAN Shareholding History

Dec '23MarJunSepDec '24Mar0.80%1.38%1.55%2.34%2.30%2.30%

Mutual Funds Invested in AMRUTANJAN

Mutual Funds Invested in AMRUTANJAN

No mutual funds holding trends are available

Top 2 Mutual Funds holding Amrutanjan Health Care Ltd



Funds (Top 2)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
5.0932%0.64%0.00%36/83 (+30)
2.4792%2.51%0.13%10/31 (+1)

Compare 3-month MF holding change on Screener

AMRUTANJAN Insider Trades & Bulk Stock Deals

AMRUTANJAN Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing AMRUTANJAN stock

smallcases containing AMRUTANJAN stock

Looks like this stock is not in any smallcase yet.

AMRUTANJAN Events

AMRUTANJAN Events

AMRUTANJAN Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AMRUTANJAN has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.65%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.49 every year

Dividends

Corp. Actions

Announcements

Legal Orders

AMRUTANJAN Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

AMRUTANJAN has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.65%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.49 every year

AMRUTANJAN Upcoming Dividends

AMRUTANJAN Upcoming Dividends

No upcoming dividends are available

AMRUTANJAN Past Dividends

AMRUTANJAN Past Dividends

Cash Dividend

Ex DateEx DateFeb 18, 2025

Interim 2
Interim 2 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Feb 18, 2025

Cash Dividend

Ex DateEx DateNov 22, 2024

Interim 1
Interim 1 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Nov 22, 2024

Cash Dividend

Ex DateEx DateSep 13, 2024

Final
Final | Div/Share: ₹2.60

Dividend/Share

2.60

Ex DateEx Date

Sep 13, 2024

Cash Dividend

Ex DateEx DateFeb 20, 2024

Interim 2
Interim 2 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Feb 20, 2024

Cash Dividend

Ex DateEx DateNov 23, 2023

Interim 1
Interim 1 | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Nov 23, 2023

AMRUTANJAN Stock News & Opinions

AMRUTANJAN Stock News & Opinions

Earnings
Amrutanjan Health Care standalone net profit rises 11.13% in the March 2025 quarter

Net profit of Amrutanjan Health Care rose 11.13% to Rs 15.18 crore in the quarter ended March 2025 as against Rs 13.66 crore during the previous quarter ended March 2024. Sales rose 6.57% to Rs 135.41 crore in the quarter ended March 2025 as against Rs 127.06 crore during the previous quarter ended March 2024. For the full year,net profit rose 13.03% to Rs 50.83 crore in the year ended March 2025 as against Rs 44.97 crore during the previous year ended March 2024. Sales rose 7.26% to Rs 451.82 crore in the year ended March 2025 as against Rs 421.23 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales135.41127.06 7 451.82421.23 7 OPM %13.0712.78 -12.8812.30 - PBDT22.4821.14 6 75.6668.00 11 PBT20.8619.61 6 69.1361.94 12 NP15.1813.66 11 50.8344.97 13 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Amrutanjan Health Care recommends final dividend

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 15 May 2025, inter alia, have recommended the final dividend of Rs 2.6 per equity Share (i.e. 260%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Amrutanjan Health Care to announce Quarterly Result

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 15 May 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Amrutanjan Health Care standalone net profit rises 10.32% in the December 2024 quarter

Net profit of Amrutanjan Health Care rose 10.32% to Rs 19.25 crore in the quarter ended December 2024 as against Rs 17.45 crore during the previous quarter ended December 2023. Sales rose 4.92% to Rs 122.75 crore in the quarter ended December 2024 as against Rs 116.99 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales122.75116.99 5 OPM %19.0218.45 - PBDT27.6525.29 9 PBT25.9923.71 10 NP19.2517.45 10 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Board of Amrutanjan Health Care recommends Second Interim dividend

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 12 February 2025, inter alia, have recommended the Second Interim dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Amrutanjan Health Care schedules board meeting

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Board of Amrutanjan Health Care recommends first interim dividend

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 12 November 2024, inter alia, have recommended the first interim dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Amrutanjan Health Care standalone net profit rises 72.26% in the September 2024 quarter

Net profit of Amrutanjan Health Care rose 72.26% to Rs 11.80 crore in the quarter ended September 2024 as against Rs 6.85 crore during the previous quarter ended September 2023. Sales rose 10.68% to Rs 109.92 crore in the quarter ended September 2024 as against Rs 99.31 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales109.9299.31 11 OPM %12.376.89 - PBDT17.5910.76 63 PBT15.949.21 73 NP11.806.85 72 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Amrutanjan Health Care to convene board meeting

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Amrutanjan Health Care to conduct AGM

Amrutanjan Health Care announced that the 87th Annual General Meeting (AGM) of the company will be held on 23 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Amrutanjan Health Care Ltd (AMRUTANJAN) today?

    The share price of AMRUTANJAN as on 9th July 2025 is ₹720. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Amrutanjan Health Care Ltd (AMRUTANJAN) share?

    The past returns of Amrutanjan Health Care Ltd (AMRUTANJAN) share are
    • Past 1 week: -0.31%
    • Past 1 month: -0.06%
    • Past 3 months: 13.06%
    • Past 6 months: -0.30%
    • Past 1 year: -9.73%
    • Past 3 years: -10.02%
    • Past 5 years: 99.24%

  3. What are the peers or stocks similar to Amrutanjan Health Care Ltd (AMRUTANJAN)?
  4. What is the dividend yield % of Amrutanjan Health Care Ltd (AMRUTANJAN) share?

    The current dividend yield of Amrutanjan Health Care Ltd (AMRUTANJAN) is 0.65.

  5. What is the market cap of Amrutanjan Health Care Ltd (AMRUTANJAN) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Amrutanjan Health Care Ltd (AMRUTANJAN) is ₹2049.74 Cr as of 9th July 2025.

  6. What is the 52 week high and low of Amrutanjan Health Care Ltd (AMRUTANJAN) share?

    The 52-week high of Amrutanjan Health Care Ltd (AMRUTANJAN) is ₹862.60 and the 52-week low is ₹544.10.

  7. What is the PE and PB ratio of Amrutanjan Health Care Ltd (AMRUTANJAN) stock?

    The P/E (price-to-earnings) ratio of Amrutanjan Health Care Ltd (AMRUTANJAN) is 40.33. The P/B (price-to-book) ratio is 7.11.

  8. Which sector does Amrutanjan Health Care Ltd (AMRUTANJAN) belong to?

    Amrutanjan Health Care Ltd (AMRUTANJAN) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Amrutanjan Health Care Ltd (AMRUTANJAN) shares?

    You can directly buy Amrutanjan Health Care Ltd (AMRUTANJAN) shares on Tickertape. Simply sign up, connect your demat account and place your order.